Insights on attenuating autophagy cellular and molecular pathways versus methotrexate-induced toxicity via liposomal turmeric therapy
Tóm tắt
Methotrexate (MX), a competitive inhibitor of dihydrofolate reductase, can inhibit DNA and RNA production and is a powerful anticancer agent widely utilized in clinical practice for treating nonneoplastic maladies, as psoriasis and rheumatoid arthritis; meanwhile, its probable prescription dose and interval of administration are strictly limited due to dose-related organ damage. Former studies verified that kidney, brain, liver, and lung harms are prospective obstacles of methotrexate administration. To understand the machinery of methotrexate-prompt toxicity, various mechanisms were investigated. The former is an autophagy defense mechanism; autophagy is a self-digesting mechanism responsible for the removal of damaged organelles and malformed proteins by lysosome. The contemporary article hypothesized that turmeric or its liposomal analog could defeat autophagy of MX-induced acute toxicity. Methotrexate, in a dose of 1.5 mg/kg, was administered intravenously followed by turmeric and liposomal turmeric treatment in a dose of 5 mg/kg for 30 days in rats. Increment in autophagy (AUTP) consent by MX administration was attenuated by concurrent treatment via turmeric and liposomal turmeric that was reliable on the alteration in apoptotic markers. The assembly of FOXO-3 in serum post methotrexate administration was suppressed by concurrent treatment via liposomal turmeric. Apoptosis/autophagic marker investigation was evaluated through the gene expression of Bax (BCL2-associated X protein)/Bcl2 (B-cell lymphoma 2)/P53 (tumor protein P53)/SiRT-1 (sirtuin silent mating-type information regulation 2 homolog 1) and FOXO-3 (forkhead box transcription factor-3)/ERDJ-4 (endoplasmic reticulum localized DnaJ homologs)/BNP (brain natriuretic peptide B) signaling. The cell death of all cells was categorized to achieve autophagy. Interestingly, Bax/Bcl2/P53/SiRT-1 signaling pathways were downregulated, contributing to inhibiting the initiation of autophagy. Meanwhile, FOXO-3/BNP/ERDJ-4 reduction-implicated noncanonical autophagy pathways were involved in methotrexate-induced autophagy, whereas this change was suppressed when turmeric was administered in liposomal form. These outcomes recommended that liposomal turmeric prevents MX-induced acute toxicity through its autophagy, antioxidant, and antiapoptotic properties.
Tài liệu tham khảo
Tang D, Kang R, Livesey KM, Cheh CW, Farkas A, Loughran P, Hoppe G, Bianchi ME, Tracey KJ, Zeh HJ, Lotze MT (2010) Endogenous HMGB1 regulates autophagy. J. Cell Biol 190(5):881–892
Xu K, Cai YS, Lu SM, Li XL, Liu L, Li Z, Liu H, Xu PK (2015) Autophagy induction contributes to the resistance to methotrexate treatment in rheumatoid arthritis fibroblast-like synovial cells through high mobility group box chromosomal protein 1. Arthritis Res Ther 17:374
Misra S, Bagchi A, Sarkar A, Niyogi S, Bhattacharjee D, Chatterjee S, Mondal S, Chattopadhyay A, Saha A, Chatterjee S, Sinhamahapatra P, Chakrabarti P, Chatterjee M, Ghosh A (2021) Methotrexate and theaflavin-3, 3'-digallate synergistically restore the balance between apoptosis and autophagy in synovial fibroblast of RA: an ex vivo approach with cultured human RA FLS. Inflammopharmacology 29(5):1427–1442
Kiffin R, Bandyopadhyay U, Cuervo AM (2006) Oxidative stress and autophagy. Antioxid Redox Signal 8(1-2):152–162
Ou X, Lee MR, Huang X, Messina-Graham S, Broxmeyer HE (2014) SIRT1 positively regulates autophagy and mitochondria function in embryonic stem cells under oxidative stress. Stem Cells 32(5):1183–1194
Abdelsamia EM, Khaleel SA, Balah A, Abdel Baky NA (2019) Tumeric augments the cardioprotective effect of metformin in an experimental model of type I diabetes mellitus; impact of Nrf2/HO-1 and JAK/STAT pathways. BioMe Pharmacother 109:2136–2144
Ohbayashi M, Kubota S, Kawase A, Kohyama N, Kobayashi Y, Yamamoto T (2014) Involvement of epithelial-mesenchymal transition in methotrexate-induced pulmonary fibrosis. J Toxicol Sci 39:319–330
Zendedel E, Butler AE, Atkin SL, Sahebkar A (2018) Impact of tumeric on sirtuins: a review. J Cell Biochem 119(12):10291–10300. https://doi.org/10.1002/jcb.27371
Tousson E, Zaki ZT, Abu-Shaeir WA, Hassan H (2014) Methotrexate-induced hepatic and renal toxicity: role of L-carnitine in treatment. Biomed Biotechnol 2(4):85–92
Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351–358
Moron MS, Depierre JW, Mannervik B (1979) Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochim Biophys Acta 582:67–78
Kadry MO (2019) Liposomal glutathione as a promising candidate for immunological rheumatoid arthritis therapy. Heliyon 5(7):e02162
Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 25:402–408
Mahmoud AM, Hussein OE, Hozayen WG, Abd El-Twab SM (2017) Methotrexate hepatotoxicity is associated with oxidative stress, and down-regulation of PPARγ and Nrf2: protective effect of 18β-glycyrrhetinic acid. Chem Biol Interact 270:59–72
Serrano-Mollar A, Closa D, Prats N, Blesa S, Martinez-Losa M, Cortijo J, Estrela JM, Morcillo EJ, Bulbena O (2003) In vivo antioxidant treatment protects against bleomycin induced lung damage in rats. Br J Pharmacol 138:1037–1048
Isik M, Beydemir S, Yilmaz A, Naldan ME, Aslan HE, Gulcin I (2017) Oxidative stress and mRNA expression of acetylcholinesterase in the leukocytes of ischemic patients. Biomed Pharmacother 87:561–567
Gui YS, Wang L, Tian X, Li X, Ma A, Zhou W, Zeng N, Zhang J, Cai B, Zhang H, Chen JY, Xu KF (2015) mTORoveractivation and compromised autophagy in the pathogenesis of pulmonary fibrosis. Plos One 10(9):e0138625
Araki T, Sasaki Y, Milbrandt J (2004) Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration. Science 305(5686):1010–1013
Chiang HL, Terlecky SR, Plant CP, Dice JF (1989) A role for a 70-kilodaton heat shock protein in lysosomal degradation of intracellular proteins. Science 246(4928):382–385 View at: Google Scholar
Shen Y, Meunier L, Hendershot LM (2002) Identification and characterization of a novel endoplasmic reticulum (ER) DnaJ homologue, which stimulates ATPase activity of BiP in vitro and is induced by ER stress. J Biol Chem 277(18):15947–15956
Crighton D, Wilkinson S, O’Prey J et al (2006) DRAM, a p53-induced modulator of autophagy, is critical for apoptosis. Cell 126(1):121–134
Tunali-Akbay T, Sehirli O, Ercan F, Sener G (2010) Resveratrol protects against methotrexate-induced hepatic injury in rats. J Pharm Sci 13(2):303–310
Tasdemir E, Maiuri MC, Galluzzi L et al (2008) Regulation of autophagy by cytoplasmic p53. Nat Cell Biol 10(6):676–687
Zhao J, Brault JJ, Schild A et al (2007) FoxO3 coordinately activates protein degradation by the autophagic/lysosomal and proteasomal pathways in atrophying muscle cells. Cell Metab 6(6):472–483 View at: Publisher Site|Google Scholar
Vardi N, Parlakpinar H, Cetin A, Erdogan A, Cetin Ozturk I (2010) Protective. Protective effect of beta-carotene on methotrexate-induced oxidative liver damage. Toxicol Pathol 38:592–597
Farsi F, Mohammadshahi M, Alavinejad P, Rezazadeh A, Zarei M, Engali KA (2016) Functions of coenzyme Q10 supplementation on liver enzymes, markers of systemic inflammation, and adipokines in patients affected by nonalcoholic fatty liver disease: a double blind, placebo-controlled, randomized clinical trial. J Am Coll Nutr 35(4):346–353
Vasiliev AV, Martinova EA, Sharanova NV, Gapparov MM (2011) Effects of coenzyme Q10 on rat liver cells under conditions of metabolic stress. Bull Exp Biol Med 150(4):416–419
Ashkani ES, Esmaeilzadeh E, Bagheri F, Emami Y, Farjam M (2013) The effect of co-enzyme Q10 on acute liver damage in rats, a biochemical and pathological study. Hepat Mon 13(8):e13685
Emam AM, Georgy GS, Shaker OG, Fawzy HM, Zaki HF (2016) Protective effects of alpha-lipoic acid and coenzyme Q10 on lipopolysaccharide-induced liver injury in rats. Pharm. Lett. 8(19):176–182
Baehrecke EH (2005) Autophagy: dual roles in life and death? Nat Rev Mol Cell Biol 6(6):505–510 View at: Publisher Site | Google Scholar
Edinger AL, Thompson CB (2004) Death by design: apoptosis, necrosis and autophagy. Curr Opin Cell Biol 16(6):663–669 View at: Publisher Site |Google Scholar
Imai SI, Armstrong CM, Kaeberlein M, Guarente L (2000) Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature 403(6771):795–800 View at: Publisher Site | Google Scholar
Wood JG, Rogina B, Lavu S et al (2004) Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature 430(7000):686–689 View at: Google Scholar
In HL, Cao L, Mostoslavsky R et al (2008) A role for the NAD-dependent deacetylase Sirt1 in the regulation of autophagy. Proc Natl Acad Sci USA 105(9):3374–3379
Biason-Lauber A, Boni-Schnetzler M, Hubbard BP, Bouzakri K, Brunner A, Cavelti-Weder C et al (2013) Identification of a SIRT1 mutation in a family with type 1 diabetes. Cell Metab 17(3):448–455. https://doi.org/10.1016/j.cmet.2013.02.001
Kupis W, Palyga J, Tomal E, Niewiadomska E (2016) The role of sirtuins in cellular homeostasis. J Physiol Biochem 72(3):371–380. https://doi.org/10.1007/s13105-016-0492-6
Liguori I, Russo G, Curcio F, Bulli G, Aran L, Della-Morte D et al (2018) Oxidative stress, aging, and diseases. Clin Interv Aging 13:757–772
Sun T, Zhang Y, Zhong S, Gao F, Chen Y, Wang B et al (2018) N-n-butyl haloperidol iodide, a derivative of the anti-psychotic haloperidol, antagonizes hypoxia/reoxygenation injury by inhibiting an Egr-1/ROS positive feedback loop in H9c2 cells. Front Pharmacol 9(19):19. https://doi.org/10.3389/fphar.2018.00019
Zhang T, Chi Y, Ren Y, Du C, Shi Y, Li Y (2019) Resveratrol reduces oxidative stress and apoptosis in podocytes via Sir2-related enzymes, Sirtuins1 (SIRT1)/peroxisome proliferator-activated receptor gamma co-activator 1alpha (PGC-1alpha) axis. Med Sci Monit 25:1220–1231. https://doi.org/10.12659/MSM.911714
Kauppinen A, Suuronen T, Ojala J, Kaarniranta K, Salminen A (2013) Antagonistic crosstalk between NF-kappaB and SIRT1 in the regulation of inflammation and metabolic disorders. Cell Signal 25(10):1939–1948. https://doi.org/10.1016/j.cellsig.2013.06.007
Rodgers JT, Lerin C, Haas W, Gygi SP, Spiegelman BM, Puigserver P (2005) Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature 434(7029):113–118. https://doi.org/10.1038/nature03354
Ma X, Sun Z, Han X, Li S, Jiang X, Chen S, et al (2019) Neuroprotective Effect of Resveratrol via Activation of Sirt1 Signaling in a Rat Model of Combined Diabetes and Alzheimer’s Disease. Front Neurosci 13:1400:1400. https://doi.org/10.3389/fnins.2019.01400
Yeung F, Hoberg JE, Ramsey CS, Keller MD, Jones DR, Frye RA et al (2004) Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J 23(12):2369–2380. https://doi.org/10.1038/sj.emboj.7600244
Ren Z, He H, Zuo Z, Xu Z, Wei Z, Deng J (2019) The role of different SIRT1-mediated signaling pathways in toxic injury. Cell Mol Biol Lett 24:36. https://doi.org/10.1186/s11658-019-0158-9
Wong A, Woodcock EA (2009) FoxO proteins and cardiac pathology. Adv Exp Med Biol 665:78–89. https://doi.org/10.1007/978-1-4419-1599-3_6
Brunet A, Sweeney LB, Sturgill JF, Chua KF, Greer PL, Lin Y et al (2004) Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 303(5666):2011–2015. https://doi.org/10.1126/science.1094637
Zhang H, Zhao Z, Pang X, Yang J, Yu H, Zhang Y et al (2017) MiR-34a/sirtuin-1/foxo3a is involved in genistein protecting against ox-LDL-induced oxidative damage in HUVECs. Toxicol Lett 277:115–122. https://doi.org/10.1016/j.toxlet.2017.07.216
Gu X, Han D, Chen W, Zhang L, Lin Q, Gao J et al (2016) SIRT1-mediated FoxOs pathways protect against apoptosis by promoting autophagy in osteoblast-like MC3T3-E1 cells exposed to sodium fluoride. Oncotarget 7(40):65218–65230
Wang S, Moustaid-Moussa N, Chen L, Mo H, Shastri A, Su R et al (2014) Novel insights of dietary polyphenols and obesity. J Nutr Biochem 25(1):1–18
Mercurio V, Pucci G, Bosso G, Fazio V, Battista F, Iannuzzi A et al (2020) A nutraceutical combination reduces left ventricular mass in subjects with metabolic syndrome and left ventricular hypertrophy: a multicenter, randomized, double-blind, placebo-controlled trial. Clin Nutr 39(5):1379–1384. https://doi.org/10.1016/j.clnu.2019.06.026
Miceli M, Bontempo P, Nebbioso A, Altucci L (2014) Natural compounds in epigenetics: a current view. Food Chem Toxicol 73:71–83. https://doi.org/10.1016/j.fct.2014.08.005
McCubrey JA, Lertpiriyapong K, Steelman LS, Abrams SL, Yang LV, Murata RM et al (2017) Effects of resveratrol, tumeric, berberine and other nutraceuticals on aging, cancer development, cancer stem cells and microRNAs. Aging (Albany NY) 9(6):1477–1536
Serafini MM, Catanzaro M, Fagiani F, Simoni E, Caporaso R, Dacrema M et al (2019) Modulation of Keap1/Nrf2/ARE signaling pathway by curcuma- and garlic-derived hybrids. Front Pharmacol 10(1597):1597. https://doi.org/10.3389/fphar.2019.01597
Zhang X, Wu J, Ye B, Wang Q, Xie X, Shen H (2016) Protective effect of tumeric on TNBS-induced intestinal inflammation is mediated through the JAK/STAT pathway. BMC Complement Altern Med 16(1):299. https://doi.org/10.1186/s12906-016-1273-z
Gupta SC, Patchva S, Koh W, Aggarwal BB (2012) Discovery of tumeric, a component of golden spice, and its miraculous biological activities. Clin Exp Pharmacol Physiol 39(3):283–299. https://doi.org/10.1111/j.1440-1681.2011.05648.x
Yang Y, Duan W, Lin Y, Yi W, Liang Z, Yan J et al (2013) SIRT1 activation by tumeric pretreatment attenuates mitochondrial oxidative damage induced by myocardial ischemia reperfusion injury. Free Radic Biol Med 65:667–679
Iside C, Scafuro M, Nebbioso A, Altucci L (2020) SIRT1 activation by natural phytochemicals: an overview. Front Pharmacol. https://doi.org/10.3389/fphar.2020.01225